Literature DB >> 19634704

Role of cholesterol in Mycobacterium tuberculosis infection.

Maurine D Miner1, Jennifer C Chang, Amit K Pandey, Christopher M Sassetti, David R Sherman.   

Abstract

Mycobacterium tuberculosis (MTB) acquisition and utilization of nutrients within the host cell is poorly understood, although it has been hypothesized that host lipids probably play an important role in MTB survival. Cholesterol has recently been identified as an important lipid for mycobacterial infection. The mce4 transport system is required for cholesterol import into bacterial cells, and deletion of mce4 locus resulted in severe attenuation in a chronic mouse model of infection. However, it has remained unclear what additional bacterial functions were required for utilization of this sterol. We have found that the igr locus, which was previously found essential for intracellular growth and virulence of MTB, is required for cholesterol metabolism: igr-deficient bacteria cannot grow using cholesterol as a primary carbon source. The growth-inhibitory effect of cholesterol in vitro depends on cholesterol import, as the delta igr mutant growth defect during the early phase of disease is completely suppressed by mutating mce4, implicating cholesterol intoxication as the primary mechanism of attenuation. We conclude that M. tuberculosis metabolizes cholesterol throughout the course of infection, and that degradation of this sterol is crucial for bacterial persistence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634704

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  40 in total

1.  Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.

Authors:  Jonathan B Johnston; Arti A Singh; Anaelle A Clary; Chiung-Kuan Chen; Patricia Y Hayes; Sharon Chow; James J De Voss; Paul R Ortiz de Montellano
Journal:  Bioorg Med Chem       Date:  2012-05-11       Impact factor: 3.641

Review 2.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

Review 3.  Acid Fasting: Modulation of Mycobacterium tuberculosis Metabolism at Acidic pH.

Authors:  Jacob J Baker; Shelby J Dechow; Robert B Abramovitch
Journal:  Trends Microbiol       Date:  2019-07-16       Impact factor: 17.079

4.  DES-Mutation: System for Exploring Links of Mutations and Diseases.

Authors:  Vasiliki Kordopati; Adil Salhi; Rozaimi Razali; Aleksandar Radovanovic; Faroug Tifratene; Mahmut Uludag; Yu Li; Ameerah Bokhari; Ahdab AlSaieedi; Arwa Bin Raies; Christophe Van Neste; Magbubah Essack; Vladimir B Bajic
Journal:  Sci Rep       Date:  2018-09-06       Impact factor: 4.379

Review 5.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

6.  Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.

Authors:  Emily R Driver; Gavin J Ryan; Donald R Hoff; Scott M Irwin; Randall J Basaraba; Igor Kramnik; Anne J Lenaerts
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

7.  The Mycobacterium tuberculosis regulatory network and hypoxia.

Authors:  James E Galagan; Kyle Minch; Matthew Peterson; Anna Lyubetskaya; Elham Azizi; Linsday Sweet; Antonio Gomes; Tige Rustad; Gregory Dolganov; Irina Glotova; Thomas Abeel; Chris Mahwinney; Adam D Kennedy; René Allard; William Brabant; Andrew Krueger; Suma Jaini; Brent Honda; Wen-Han Yu; Mark J Hickey; Jeremy Zucker; Christopher Garay; Brian Weiner; Peter Sisk; Christian Stolte; Jessica K Winkler; Yves Van de Peer; Paul Iazzetti; Diogo Camacho; Jonathan Dreyfuss; Yang Liu; Anca Dorhoi; Hans-Joachim Mollenkopf; Paul Drogaris; Julie Lamontagne; Yiyong Zhou; Julie Piquenot; Sang Tae Park; Sahadevan Raman; Stefan H E Kaufmann; Robert P Mohney; Daniel Chelsky; D Branch Moody; David R Sherman; Gary K Schoolnik
Journal:  Nature       Date:  2013-07-03       Impact factor: 49.962

8.  FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis.

Authors:  Christin M Schaefer; Rui Lu; Natasha M Nesbitt; Johannes Schiebel; Nicole S Sampson; Caroline Kisker
Journal:  Structure       Date:  2014-12-04       Impact factor: 5.006

9.  Hyperlipidemia offers protection against Leishmania donovani infection: role of membrane cholesterol.

Authors:  June Ghosh; Shantanabha Das; Rajan Guha; Debopam Ghosh; Kshudiram Naskar; Anjan Das; Syamal Roy
Journal:  J Lipid Res       Date:  2012-10-10       Impact factor: 5.922

10.  A highly conserved mycobacterial cholesterol catabolic pathway.

Authors:  Esther García-Fernández; Daniel J Frank; Beatriz Galán; Petrea M Kells; Larissa M Podust; José L García; Paul R Ortiz de Montellano
Journal:  Environ Microbiol       Date:  2013-03-14       Impact factor: 5.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.